Nuzenio

Abcellera Biologics

Abcellera Biologics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 23 latest news signals 11 publisher sources 100/100 entity strength

Latest news

AbCellera (NASDAQ:ABCL) Shares Surge Ahead of Monday's ABCL635 Phase 2 Trial Results - TechStock²TechStock² · Sat, 08 Aug 2026 14:45:00 GMTAbCellera Biologics | 8-K: Current report - MoomooMoomoo · Sat, 08 Aug 2026 02:26:46 GMTABCL Looks 34.6% Overvalued on GF Value™ - GuruFocusGuruFocus · Sat, 08 Aug 2026 00:47:13 GMTStocks to Watch: AbCellera - MoomooMoomoo · Fri, 07 Aug 2026 23:36:50 GMT12 Health Care Stocks Moving In Friday's After-Market Session - BenzingaBenzinga · Fri, 07 Aug 2026 21:05:58 GMTAbCellera to Release Phase 2 Top-Line Results for ABCL635 and Host Investor Call Aug 10 - TradingViewTradingView · Fri, 07 Aug 2026 20:53:02 GMTAbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 - Business WireBusiness Wire · Fri, 07 Aug 2026 20:30:00 GMTABCL Maintained by Stifel -- Price Target Raised to $9.00 - GuruFocusGuruFocus · Thu, 06 Aug 2026 16:08:38 GMT

Timeline

Sat, 08 Aug 2026 14:45:00 GMTAbCellera (NASDAQ:ABCL) Shares Surge Ahead of Monday's ABCL635 Phase 2 Trial Results - TechStock²
Sat, 08 Aug 2026 02:26:46 GMTAbCellera Biologics | 8-K: Current report - Moomoo
Sat, 08 Aug 2026 00:47:13 GMTABCL Looks 34.6% Overvalued on GF Value™ - GuruFocus
Fri, 07 Aug 2026 23:36:50 GMTStocks to Watch: AbCellera - Moomoo
Fri, 07 Aug 2026 21:05:58 GMT12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Fri, 07 Aug 2026 20:53:02 GMTAbCellera to Release Phase 2 Top-Line Results for ABCL635 and Host Investor Call Aug 10 - TradingView

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Abcellera Biologics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.